Artelo Biosciences 8-K: Convertible Notes Details

Ticker: ARTL · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1621221

Sentiment: neutral

Topics: convertible-debt, financing, securities

Related Tickers: ARTL

TL;DR

ARTL convertible notes can convert to stock or warrants at $1.04.

AI Summary

Artelo Biosciences, Inc. filed an 8-K on July 11, 2025, reporting on its financial condition and other events. The filing details convertible notes with provisions for conversion into common stock or warrants at $1.04 per share over a five-year period. Specific financial figures and dates related to these notes are included.

Why It Matters

This filing provides crucial details about the terms and conversion features of Artelo Biosciences' convertible notes, impacting potential dilution and shareholder value.

Risk Assessment

Risk Level: medium — Convertible notes can lead to significant dilution for existing shareholders if converted.

Key Numbers

Key Players & Entities

FAQ

What are the specific terms for the conversion of the unsecured convertible notes?

The convertible notes are subject to voluntary and automatic conversion provisions into the Company's common stock, and also into warrants to purchase common stock for a five-year period at a price of $1.04.

What is the conversion price for the convertible notes?

The conversion price for the convertible notes is $1.04.

What is the duration of the conversion period for the convertible notes?

The conversion period for the convertible notes is five years.

What types of securities can the convertible notes be converted into?

The convertible notes can be converted into the Company's common stock or warrants to purchase the Company's common stock.

When were the unsecured convertible notes issued or last modified?

The filing references dates such as 2025-02-28 and 2025-06- in relation to the unsecured convertible notes, suggesting activity around these times.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding ARTELO BIOSCIENCES, INC. (ARTL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing